Pathophysiology of atherosclerosis

S Jebari-Benslaiman, U Galicia-García… - International journal of …, 2022 - mdpi.com
Atherosclerosis is the main risk factor for cardiovascular disease (CVD), which is the leading
cause of mortality worldwide. Atherosclerosis is initiated by endothelium activation and …

Oxidative stress and antioxidant treatments in cardiovascular diseases

W Wang, PM Kang - Antioxidants, 2020 - mdpi.com
Oxidative stress plays a key role in many physiological and pathological conditions. The
intracellular oxidative homeostasis is tightly regulated by the reactive oxygen species …

Non-coding RNAs in cardiovascular cell biology and atherosclerosis

F Fasolo, K Di Gregoli, L Maegdefessel… - Cardiovascular …, 2019 - academic.oup.com
Atherosclerosis underlies the predominant number of cardiovascular diseases and remains
a leading cause of morbidity and mortality worldwide. The development, progression and …

lncRNA/MicroRNA interactions in the vasculature

MD Ballantyne, RA McDonald… - Clinical Pharmacology & …, 2016 - Wiley Online Library
MicroRNA (miRNA) have gained widespread attention for their role in diverse vascular
processes including angiogenesis, apoptosis, proliferation, and migration. Despite great …

The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis

L Benetatos, E Hatzimichael, E Londin… - Cellular and molecular …, 2013 - Springer
The mammalian genome is transcribed in a developmentally regulated manner, generating
RNA strands ranging from long to short non-coding RNA (ncRNAs). NcRNAs generated by …

MicroRNAs in the pathobiology and therapy of atherosclerosis

B Laffont, KJ Rayner - Canadian Journal of Cardiology, 2017 - Elsevier
MicroRNAs are short noncoding RNAs, expressed in humans and involved in sequence-
specific post-transcriptional regulation of gene expression. They have emerged as key …

The molecular basis of predicting atherosclerotic cardiovascular disease risk

M Nayor, KJ Brown, RS Vasan - Circulation research, 2021 - Am Heart Assoc
Atherosclerotic cardiovascular disease (ASCVD) proceeds through a series of stages:
initiation, progression (or regression), and complications. By integrating known biology …

MicroRNAs as potential biomarkers in atherosclerosis

A Churov, V Summerhill, A Grechko… - International Journal of …, 2019 - mdpi.com
Atherosclerosis is a complex multifactorial disease that, despite advances in lifestyle
management and drug therapy, remains to be the major cause of high morbidity and …

CARMN Loss Regulates Smooth Muscle Cells and Accelerates Atherosclerosis in Mice

F Vacante, J Rodor, MK Lalwani, AD Mahmoud… - Circulation …, 2021 - Am Heart Assoc
Rationale: In the microenvironment of atherosclerotic lesions, vascular smooth muscle cells
(vSMCs) switch to a dedifferentiated state but the underlying molecular mechanisms driving …

Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control

D Santovito, V De Nardis, P Marcantonio… - The Journal of …, 2014 - academic.oup.com
Context: Type 2 diabetes is a chronic disease characterized by inadequate β-cell response
to the progressive insulin resistance. MicroRNAs (miRNAs) are short, endogenous …